Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Morley

Showing results (391-400 of 399) with videos related to

Pageof 40
Sort By:
You have reached the last page of results.This site can display upto 399 results.
British Journal of Cancer|March 11, 2015
The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trialD T Arnold, C E Hooper, A Morley, et al.
British Journal of Cancer|March 11, 2015
The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognosticationC E Hooper, I D Lyburn, J Searle, et al.
Science Advances|June 20, 2025
Thermodynamic phase transitions of nematic order in magnetic helicesZoey Tumbleson, Sophie A Morley, Emily Hollingworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2021
Reply to T. Shimoi et al and Y. Shimanuki et alIngrid A Mayer, Fengmin Zhao, Carlos L Arteaga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2021
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131Ingrid A Mayer, Fengmin Zhao, Carlos L Arteaga, et al.
Cancer|January 18, 2024
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131Karen L Smith, Fengmin Zhao, Ingrid A Mayer, et al.
Global Change Biology|January 14, 2020
Invasive non-native species likely to threaten biodiversity and ecosystems in the Antarctic Peninsula regionKevin A Hughes, Oliver L Pescott, Jodey Peyton, et al.
JCO Oncology Advances|May 18, 2026
Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 TrialMoriah Forster, Fengmin Zhao, Sarah Bell, et al.
Biological Conservation|May 26, 2021
Global COVID-19 lockdown highlights humans as both threats and custodians of the environmentAmanda E Bates, Richard B Primack, Brandy S Biggar, et al.
Pageof 40

Showing results (391-400 of 399) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 399 results.
British Journal of Cancer|March 11, 2015
The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trialD T Arnold, C E Hooper, A Morley, et al.
British Journal of Cancer|March 11, 2015
The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognosticationC E Hooper, I D Lyburn, J Searle, et al.
Science Advances|June 20, 2025
Thermodynamic phase transitions of nematic order in magnetic helicesZoey Tumbleson, Sophie A Morley, Emily Hollingworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2021
Reply to T. Shimoi et al and Y. Shimanuki et alIngrid A Mayer, Fengmin Zhao, Carlos L Arteaga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2021
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131Ingrid A Mayer, Fengmin Zhao, Carlos L Arteaga, et al.
Cancer|January 18, 2024
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131Karen L Smith, Fengmin Zhao, Ingrid A Mayer, et al.
Global Change Biology|January 14, 2020
Invasive non-native species likely to threaten biodiversity and ecosystems in the Antarctic Peninsula regionKevin A Hughes, Oliver L Pescott, Jodey Peyton, et al.
JCO Oncology Advances|May 18, 2026
Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 TrialMoriah Forster, Fengmin Zhao, Sarah Bell, et al.
Biological Conservation|May 26, 2021
Global COVID-19 lockdown highlights humans as both threats and custodians of the environmentAmanda E Bates, Richard B Primack, Brandy S Biggar, et al.
Pageof 40